Macquarie Group
ADPT icon

Macquarie Group’s Adaptive Biotechnologies ADPT Stock Holding History

Macquarie Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,104,414
Closed -$31.5M – 857
2025
Q3 		$31.5M Buy
2,104,414
+1,444,358
+219% +$17.6M 0.04% 539
2025
Q2 		$7.69M Buy
+660,056
New +$6M 0.01% 869
2024
Q2 		– Sell
-121,185
Closed -$389K – 1893
2024
Q1 		$389K Sell
121,185
-2,113
-2% -$8.18K ﹤0.01% 1467
2023
Q4 		$604K Buy
123,298
+17,931
+17% +$81.8K ﹤0.01% 1449
2023
Q3 		$574K Buy
105,367
+2,055
+2% +$13.6K ﹤0.01% 1428
2023
Q2 		$693K Buy
103,312
+15,781
+18% +$117K ﹤0.01% 1417
2023
Q1 		$773K Buy
87,531
+29,655
+51% +$261K ﹤0.01% 1403
2022
Q4 		$442K Sell
57,876
-18,796
-25% -$146K ﹤0.01% 1531
2022
Q3 		$553K Sell
76,672
-1,323
-2% -$12.5K ﹤0.01% 1512
2022
Q2 		$631K Sell
77,995
-351
-0.4% -$3.09K ﹤0.01% 1565
2022
Q1 		$1.09M Buy
78,346
+3,546
+5% +$55.8K ﹤0.01% 1532
2021
Q4 		$2.1M Buy
74,800
+12,344
+20% +$378K ﹤0.01% 1359
2021
Q3 		$2.12M Buy
62,456
+7,394
+13% +$267K ﹤0.01% 1370
2021
Q2 		$2.25M Buy
55,062
+4,553
+9% +$177K ﹤0.01% 1379
2021
Q1 		$2.03M Buy
50,509
+10,847
+27% +$587K ﹤0.01% 1202
2020
Q4 		$2.35M Sell
39,662
-3,308
-8% -$171K ﹤0.01% 1062
2020
Q3 		$2.09M Sell
42,970
-3,151
-7% -$132K ﹤0.01% 1021
2020
Q2 		$2.23M Buy
46,121
+3,871
+9% +$141K ﹤0.01% 978
2020
Q1 		$1.17M Buy
42,250
+11,697
+38% +$326K ﹤0.01% 1051
2019
Q4 		$914K Buy
+30,553
New +$877K ﹤0.01% 1276

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Macquarie Group's ADPT Position: Q4 2025 in Review

Macquarie Group sold out of Adaptive Biotechnologies (ADPT) in Q4 2025, closing a stake of 2,104,414 shares — an estimated $31.5M sold.

Macquarie Group first reported a position in ADPT in Q4 2019 and held it in 20 quarters. The position peaked at $31.5M in Q3 2025. 283 funds tracked by Wall St. Rank hold ADPT as of Q4 2025.

  • Macquarie Group reported no remaining Adaptive Biotechnologies position as of Q4 2025 after selling out during the quarter.
  • Macquarie Group sold 2,104,414 Adaptive Biotechnologies shares in Q4 2025, an estimated $31.5M.
  • Macquarie Group first reported a position in Adaptive Biotechnologies in Q4 2019 and held it in 20 quarters.
  • Macquarie Group's Adaptive Biotechnologies position peaked at $31.5M in Q3 2025.
  • 283 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.